Leveraging Artificial Intelligence and Multi-Omics Data to Predict Opioid Addiction
Part of paid clinical trials in La Jolla, California.
- Sponsor
- University of California, San Diego
- Study ID
- NCT06540105
- Status
- Recruiting
Conditions
- Addiction, Opioid
- Opioid Use Disorder
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
The primary goal of this proposal is to validate a novel genomic and microbiome predictive model that may be used to assess a person's risk of developing opioid use disorder (OUD). The following will be tested: (1) MODUS (Measuring risk for Opioid use Disorder Using SNPs), which is a genomic panel consisting of a set number of proven single nucleotide polymorphisms (SNP) that utilizes machine learning to determine an individual's risk; and (2) MICROUD (MICRObiome for Opioid Use Disorder), which will be a novel microbiome prediction panel for OUD risk. MODUS and MICROUD will be developed using existing public datasets with genomic and microbiome data (e.g., All of Us, Human Microbiome Project). During development of these predictive models, in parallel, an external prospective validation cohort will be recruited consisting of subjects from the University of California, San Diego, Veteran Affairs of San Diego, and Veteran Affairs of Palo Alto (each site with separate IRB). The hypothesis is that MODUS and MICROUD will have high predictive potential for identifying high risk patients for OUD.
Key Dates
- Start date
- Aug 26, 2024
- Status verified
- Aug 2024
- Primary completion
- Jun 29, 2027
- Completion
- Sep 30, 2027
Study Design
- Enrollment
- 300 participants (estimated)
Arms
- Arm: Opioid Use DisorderSubjects with a history of opioid use disorder
Primary Outcome Measure
opioid use disorder at baseline based on the DSM-5 criteria [ Time Frame: baseline ]
Central Contacts
- Rodney A Gabriel, MD8586637747
- Sesh Mudumbai, MD
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of California, San Diego | La Jolla | California | 92037 | Brandon Palugod, BS Rodney A Gabriel, MD, MAS |
Find similar trials in La Jolla, CA
Related Studies
- Local Participatory Systems Dynamics to Increase Reach of Evidence Based Addiction and Mental Health CareEnrolling By Invitation · Palo Alto Veterans Institute for Research · Palo Alto, California
- A Study Comparing Oral Buprenorphine and Injectable Buprenorphine for the Treatment of Opioid Use DisorderPHASE4 · Recruiting · VA Office of Research and Development · Tuscaloosa, Alabama
- Office-based Methadone Versus Buprenorphine to Address Retention in Medication for Opioid Use Disorder Treatment.PHASE4 · Recruiting · Yale University · Oakland, California
- Standard Versus High Dose ED-Initiated Buprenorphine InductionPHASE3 · Recruiting · Yale University · Oakland, California